semaglutide drops for weight loss | Blog FDA Approves Game-Changing Weight Loss

The goal shifts from rapid reduction to metabolic control and long-term consistency

These side effects usually go away quickly

In cases where FDA-approved medications are not suitable for treating a particular patient, such as when a patient is allergic to an ingredient in the medication or when the medicine is in tablet form, which children or elderly individuals cannot swallow, compounding is performed to make the medication suitable for the patient

So while patients lost about 9.5 percent of their body weight [on average] in SELECT, the benefits of the drug seem quite clearly to be above and beyond weight loss alone

Tesamorelin (Egrifta) is FDA-approved specifically to reduce excess visceral abdominal fat in people with HIV-associated lipodystrophy

Published online June 2, 2026